Patient, treatment and discharge factors associated with hospital readmission within 30days after surgical cytoreduction for epithelial ovarian carcinoma

Hospital readmissions are common, costly and increasingly viewed as adverse events. In gynecologic oncology, data on readmissions are limited. The goal of this study was to examine the patient, treatment and discharge factors associated with unplanned readmission after cytoreductive surgery. We iden...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2013-09, Vol.130 (3), p.407-410
Main Authors: Clark, Rachel M., Growdon, Whitfield B., Wiechert, Andrew, Boruta, David, Del Carmen, Marcela, Goodman, Anne Kathryn, Bradford, Leslie, Rauh-Hain, Alejandro, Schorge, John O.
Format: Article
Language:English
Subjects:
Cytoreduction
Outcomes
Quality
Readmission
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hospital readmissions are common, costly and increasingly viewed as adverse events. In gynecologic oncology, data on readmissions are limited. The goal of this study was to examine the patient, treatment and discharge factors associated with unplanned readmission after cytoreductive surgery. We identified all patients with stages II–IV ovarian cancer who underwent surgical cytoreduction at our institution between 2003 and 2011. A retrospective chart review was performed, and clinical variables were extracted. Utilizing linear and logistic regression, these clinical variables were correlated with risk of readmission. A total of 460 patients were included in the analysis, with the majority having a stage IIIC high grade serous cancer. Optimal cytoreduction (
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2013.05.034